Athyrium Opportunities III Co-Invest 1 LP

Insider Reports History

Location
New York, NY
Signature
/s/ Athyrium Opportunities III Co-Invest 1 LP, by Athyrium Opportunities Associates Co-Invest LLC, its general partner, by Andrew Hyman, Senior Vice President, Secretary
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Athyrium Opportunities III Co-Invest 1 LP:

Company Role Class Num Shares Value Price $ Report Date Ownership
BIORA THERAPEUTICS, INC. Director, 10%+ Owner Warrant 457,250 12 Aug 2024 Indirect
BIORA THERAPEUTICS, INC. Director, 10%+ Owner 7.25% Convertible Senior Notes due 2025 0 18 Dec 2023 Indirect
BIORA THERAPEUTICS, INC. Director, 10%+ Owner 11.00% / 13.00% Convertible Senior Secured Notes due 2028 $19,595,900 12 Dec 2024 Indirect

Insider Reports Filed by Athyrium Opportunities III Co-Invest 1 LP

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BIORQ BIORA THERAPEUTICS, INC. 12 Dec 2024 1 +$1,195,994 4 Director, 10%+ Owner 16 Dec 2024, 19:32
BIORQ BIORA THERAPEUTICS, INC. 12 Aug 2024 12 $0 4 Director, 10%+ Owner 14 Aug 2024, 21:57
BIORQ BIORA THERAPEUTICS, INC. 03 Jul 2024 1 $0 4 Director, 10%+ Owner 08 Jul 2024, 21:15
BIORQ BIORA THERAPEUTICS, INC. 02 Jul 2024 1 +$1,016,906 4 Director, 10%+ Owner 05 Jul 2024, 21:00
BIORQ BIORA THERAPEUTICS, INC. 18 Dec 2023 5 $0 4 Director, 10%+ Owner 20 Dec 2023, 16:29
BIORQ BIORA THERAPEUTICS, INC. 18 Sep 2023 4 $0 4 Director, 10%+ Owner 19 Sep 2023, 16:15
BIORQ BIORA THERAPEUTICS, INC. 03 Jan 2023 1 $0 4 10%+ Owner 05 Jan 2023, 15:55
BIORQ BIORA THERAPEUTICS, INC. 09 Nov 2022 4 $0 4 10%+ Owner 14 Nov 2022, 15:30